Director general of Translational Medical Center
Shin’ichi Takeda is currently the Director of Translational Medical Center (2008-) and also the Director of Department Molecular Therapy, National Institute of Neuroscience (2000-) in the National Center of Neurology and Psychiatry. He is also a guest Professor in the Tokyo Medical and Dental University and in Tokushima University.
He received a M.D. degree from the University of Akita, School of Medicine in 1977, and then received a Ph.D. degree in Muscle Biology from Shinshu University, Graduate School in 1981. He has had a long laboratory experience including Pasteur Institute in Paris for transcriptional regulation of muscle specific genes.
On returning to Japan in 1992, he focused his research on development of molecular therapy, particularly gene therapy of muscular dystrophy and has shown a proof of concept study for multi-exon skipping of the dystrophin gene in dystrophic dogs those Dr. Takeda established with his research group. He has published more than 150 papers in Molecular Pathology and Molecular Therapy of muscular dystrophy, but his ultimate goal is to establish the effective therapy of muscular dystrophy including Duchenne muscular dystrophy (DMD).
+81 423 461 720
4-1-1 Ogawa-higashi Kodaira, Tokyo, Japan, 187-8502